{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:48:28Z","timestamp":1790423308756,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012273","name":"Lotte and John Hecht Memorial Foundation","doi-asserted-by":"publisher","award":["4286"],"award-info":[{"award-number":["4286"]}],"id":[{"id":"10.13039\/100012273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009519","name":"Ottawa Hospital Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High blood pressure is the leading cause of cardiovascular disease worldwide. The prevalence of high blood pressure is steadily rising as the population grows amongst older adults with the ageing population. Therapeutical treatments are widely available to decrease blood pressures, in addition to many lifestyle options, such as dietary changes and exercise. There is a marked preference amongst patients, as reiterated by Hypertension Canada, for more research into non-therapeutic methods for controlling blood pressure or to reduce the burden of taking many pills to control high blood pressure. Indeed, effective options do exist, especially with diet, specifically decreasing sodium and increasing potassium intake. Current public health outreach primarily focusses on sodium intake, even though potassium intake remains low in the Western world. Excellent data exist in published research that increasing potassium intake, either via dietary modification or supplements, reduces blood pressure and reduces risk of cardiovascular outcomes such as stroke. However, the advice most often provided by medical professionals is to \u2018eat more fruits and vegetables\u2019 which has little impact on patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We propose to do a clinical trial in two stages with an adaptive trial design. In the first stage, participants with high blood pressure and proven low potassium intake (measured on the basis of a 24-h urine collection) will get individually tailored dietary advice, reinforced by weekly supportive phone\/email support. At 4\u2009weeks, if there has not been a measured increase in potassium intake, participants will be prescribed an additional potassium supplement. Testing will be conducted again at 8\u2009weeks, to confirm the efficacy of the potassium supplement. Final measurements will be planned at 52\u2009weeks to observe and measure the persistence of the effect of diet or additional supplement. Concurrent measurements of sodium intake, blood pressure, participant satisfaction, and safety measures will also be done.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The results of the study will help determine the most effective method of increasing potassium intake, thus reducing blood pressure and need for blood pressure-lowering medicines, and at the same time potentially increasing participant satisfaction. The current guidelines recommend changes in diet, not a potassium supplement, to increase potassium intake; hence, the two-stage design will only add supplements if the most rigorous dietary advice does not work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This study has been registered on\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03809884\">NCT03809884<\/jats:ext-link>\n                      . Registered on January 18, 2019\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06071-9","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T08:03:11Z","timestamp":1644825791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diet or additional supplement to increase potassium intake: protocol for an adaptive clinical trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-3416","authenticated-orcid":false,"given":"Swapnil","family":"Hiremath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"5","key":"6071_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cjca.2017.03.005","volume":"33","author":"AA Leung","year":"2017","unstructured":"Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada\u2019s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557\u201376. Epub 2017\/04\/30.PubMed PMID: 28449828. https:\/\/doi.org\/10.1016\/j.cjca.2017.03.005.","journal-title":"Can J Cardiol."},{"issue":"4","key":"6071_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","volume":"35","author":"CM Lawes","year":"2004","unstructured":"Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(4):1024. Epub 2004\/04\/01. PubMed PMID: 15053002\u201333. https:\/\/doi.org\/10.1161\/01.STR.0000126208.14181.DD.","journal-title":"Stroke."},{"issue":"5","key":"6071_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cjca.2015.07.734","volume":"32","author":"RS Padwal","year":"2016","unstructured":"Padwal RS, Bienek A, McAlister FA, Campbell NR. Outcomes Research Task Force of the Canadian Hypertension Education P. Epidemiology of hypertension in Canada: an update. Can J Cardiol. 2016;32(5):687\u201394. https:\/\/doi.org\/10.1016\/j.cjca.2015.07.734 Epub 2015\/12\/30. PubMed PMID: 26711315.","journal-title":"Can J Cardiol."},{"key":"6071_CR4","volume-title":"Potassium intake for adults and children","author":"Guideline","year":"2012","unstructured":"Guideline. Potassium intake for adults and children. Geneva: World Health Organization (WHO); 2012. https:\/\/www.who.int\/publications-detail-redirect\/9789241504829. Accessed 2 May 2017"},{"issue":"25 Pt B","key":"6071_CR5","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","volume":"63","author":"RH Eckel","year":"2014","unstructured":"Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2960\u201384. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.003 Epub 2013\/11\/19. PubMed PMID: 24239922.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6071_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/CIRCULATIONAHA.116.024525","volume":"135","author":"SP Whelton","year":"2017","unstructured":"Whelton SP, Blumenthal RS. Beyond the headlines: insights on potassium supplementation for the treatment of hypertension from the Canadian Hypertension Education Program Guidelines (CHEP). Circulation. 2017;135(1):3\u20134. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024525 Epub 2016\/12\/29. PubMed PMID: 28028058; PubMed Central PMCID: PMC5217710.","journal-title":"Circulation."},{"issue":"5","key":"6071_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","volume":"32","author":"AA Leung","year":"2016","unstructured":"Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, et al. Hypertension Canada\u2019s 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32(5):569\u201388. https:\/\/doi.org\/10.1016\/j.cjca.2016.02.066 Epub 2016\/04\/28. PubMed PMID: 27118291.","journal-title":"Can J Cardiol."},{"key":"6071_CR8","doi-asserted-by":"publisher","unstructured":"Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;(3)):CD004641. https:\/\/doi.org\/10.1002\/14651858.CD004641.pub2 Epub 2006\/07\/21. PubMed PMID: 16856053.","DOI":"10.1002\/14651858.CD004641.pub2"},{"issue":"apr03 3","key":"6071_CR9","doi-asserted-by":"publisher","first-page":"f1378","DOI":"10.1136\/bmj.f1378","volume":"346","author":"NJ Aburto","year":"2013","unstructured":"Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346(apr03 3):f1378. https:\/\/doi.org\/10.1136\/bmj.f1378. Epub 2013\/04\/06. PubMed PMID: 23558164; PubMed Central PMCID: PMC4816263.","journal-title":"BMJ."},{"issue":"9","key":"6071_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.mayocp.2013.06.005","volume":"88","author":"KJ Aaron","year":"2013","unstructured":"Aaron KJ, Sanders PW. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88(9):987\u201395. https:\/\/doi.org\/10.1016\/j.mayocp.2013.06.005 Epub 2013\/09\/05. PubMed PMID: 24001491; PubMed Central PMCID: PMC3833247.","journal-title":"Mayo Clin Proc."},{"issue":"1","key":"6071_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3\u201310. https:\/\/doi.org\/10.1056\/NEJM200101043440101 Epub 2001\/01\/04. PubMed PMID: 11136953.","journal-title":"N Engl J Med."},{"issue":"8","key":"6071_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/HJH.0000000000000611","volume":"33","author":"A Binia","year":"2015","unstructured":"Binia A, Jaeger J, Hu Y, Singh A, Zimmermann D. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015;33(8):1509\u201320. https:\/\/doi.org\/10.1097\/HJH.0000000000000611 Epub 2015\/06\/04. PubMed PMID: 26039623.","journal-title":"J Hypertens."},{"issue":"4","key":"6071_CR13","doi-asserted-by":"publisher","first-page":"e0174967","DOI":"10.1371\/journal.pone.0174967","volume":"12","author":"J Poorolajal","year":"2017","unstructured":"Poorolajal J, Zeraati F, Soltanian AR, Sheikh V, Hooshmand E, Maleki A. Oral potassium supplementation for management of essential hypertension: a meta-analysis of randomized controlled trials. PLoS ONE. 2017;12(4):e0174967. https:\/\/doi.org\/10.1371\/journal.pone.0174967 Epub 2017\/04\/19. PubMed PMID: 28419159; PubMed Central PMCID: PMC5395164.","journal-title":"PLoS ONE."},{"issue":"2","key":"6071_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165\u201382. https:\/\/doi.org\/10.1001\/jama.2016.19043 Epub 2017\/01\/18. PubMed PMID: 28097354.","journal-title":"JAMA."},{"issue":"9349","key":"6071_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective SC. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903\u201313. https:\/\/doi.org\/10.1016\/s0140-6736(02)11911-8 Epub 2002\/12\/21. PubMed PMID: 12493255.","journal-title":"Lancet."},{"key":"6071_CR16","volume-title":"mortality and burden of disease attributable to selected major risks","author":"Global health risks","year":"2009","unstructured":"Global health risks. mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009. https:\/\/apps.who.int\/iris\/handle\/10665\/44203. Accessed 22 May 2017"},{"issue":"5","key":"6071_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ki.1990.295","volume":"38","author":"TJ Rabelink","year":"1990","unstructured":"Rabelink TJ, Koomans HA, Hene RJ, Dorhout Mees EJ. Early and late adjustment to potassium loading in humans. Kidney Int. 1990;38(5):942\u20137. https:\/\/doi.org\/10.1038\/ki.1990.295 Epub 1990\/11\/01. PubMed PMID: 2266680.","journal-title":"Kidney Int."},{"issue":"8","key":"6071_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/CJN.01150112","volume":"7","author":"PA Sarafidis","year":"2012","unstructured":"Sarafidis PA, Blacklock R, Wood E, Rumjon A, Simmonds S, Fletcher-Rogers J, et al. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol. 2012;7(8):1234\u201341. https:\/\/doi.org\/10.2215\/CJN.01150112 Epub 2012\/05\/19. PubMed PMID: 22595825; PubMed Central PMCID: PMC3408123.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"6071_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2215\/CJN.04451206","volume":"2","author":"CP Kovesdy","year":"2007","unstructured":"Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(5):999\u20131007. https:\/\/doi.org\/10.2215\/CJN.04451206 Epub 2007\/08\/19. PubMed PMID: 17702709.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"6071_CR20","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jcph.713","volume":"56","author":"PH Hinderling","year":"2016","unstructured":"Hinderling PH. The pharmacokinetics of potassium in humans is unusual. J Clin Pharmacol. 2016;56(10):1212\u201320. https:\/\/doi.org\/10.1002\/jcph.713 Epub 2016\/02\/09. PubMed PMID: 26854277.","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"6071_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00583639","volume":"362","author":"H Mann","year":"1976","unstructured":"Mann H, Stiller S, Korz R. Biological balance of sodium and potassium: a control system with oscillating correcting variable. Pflugers Arch. 1976;362(2):135\u20139. https:\/\/doi.org\/10.1007\/BF00583639 Epub 1976\/03\/30. PubMed PMID: 944420.","journal-title":"Pflugers Arch."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T08:10:06Z","timestamp":1644826206000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6071"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06071-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-434959\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial has received approval from the OHSN-REB (Protocol ID: 20180873-01H). The research ethics board registration with\n                      \n                      will be informed and amended if protocol modification is necessary. Eligible patients will undergo informed consent before participating in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the investigators, research staff, sponsor, or the institution has any conflicts of interest with the research involved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}